Accelerate Long Term Debt from 2010 to 2025

AXDX Stock  USD 1.04  0.02  1.89%   
Accelerate Diagnostics Long Term Debt yearly trend continues to be fairly stable with very little volatility. Long Term Debt is likely to outpace its year average in 2025. Long Term Debt is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. View All Fundamentals
 
Long Term Debt  
First Reported
2011-09-30
Previous Quarter
41.1 M
Current Value
58 M
Quarterly Volatility
57.9 M
 
Yuan Drop
 
Covid
Check Accelerate Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accelerate Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.9 M, Selling General Administrative of 41.3 M or Total Revenue of 12.3 M, as well as many indicators such as Price To Sales Ratio of 2.27, Dividend Yield of 2.0E-4 or Days Sales Outstanding of 60.38. Accelerate financial statements analysis is a perfect complement when working with Accelerate Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Accelerate Diagnostics Correlation against competitors.
For more information on how to buy Accelerate Stock please use our How to Invest in Accelerate Diagnostics guide.

Latest Accelerate Diagnostics' Long Term Debt Growth Pattern

Below is the plot of the Long Term Debt of Accelerate Diagnostics over the last few years. Long-term debt is a debt that Accelerate Diagnostics has held for over one year. Long-term debt appears on Accelerate Diagnostics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Accelerate Diagnostics balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. Accelerate Diagnostics' Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Accelerate Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Long Term Debt10 Years Trend
Slightly volatile
   Long Term Debt   
       Timeline  

Accelerate Long Term Debt Regression Statistics

Arithmetic Mean40,594,656
Geometric Mean0.00
Coefficient Of Variation133.14
Mean Deviation44,121,695
Median16,858,000
Standard Deviation54,048,369
Sample Variance2921.2T
Range145.9M
R-Value0.50
Mean Square Error2351.5T
R-Squared0.25
Significance0.05
Slope5,661,348
Total Sum of Squares43818.4T

Accelerate Long Term Debt History

202551.1 M
202441.5 M
202336.1 M
202216.9 M
2021108 M
2020145.9 M
2019130 M

Other Fundumenentals of Accelerate Diagnostics

Accelerate Diagnostics Long Term Debt component correlations

About Accelerate Diagnostics Financial Statements

Accelerate Diagnostics investors use historical fundamental indicators, such as Accelerate Diagnostics' Long Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Accelerate Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Long Term Debt41.5 M51.1 M
Short and Long Term Debt Total63.4 M85 M
Long Term Debt Total124.2 M110.9 M
Short and Long Term Debt834.9 K793.2 K
Long Term Debt To Capitalization(5.09)(4.84)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Accelerate Stock Analysis

When running Accelerate Diagnostics' price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.